Navigation Links
B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
Date:9/23/2013

BETHLEHEM, Pa., Sept. 23, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received FDA approval of 0.9% Sodium Chloride for Irrigation in 2L and 3L IV containers. The approval initiates B.Braun's launch of TITAN® XL, a line of flexible intravenous bags that offers large-volume irrigation and parenteral nutrition solutions for compounding.

B.Braun continues to lead the way in the healthcare industry by impacting the way hospitals evaluate and purchase their products – a true testament to B.Braun's ecological awareness and patient-centric philosophy. With the addition of the new TITAN containers, B.Braun will expand its line of IV products that are not manufactured with natural rubber latex, DEHP or PVC. Exposure to these toxic materials has been a growing concern for healthcare facilities around the world. Studies show that excessive exposure to DEHP can potentially lead to adverse health effects, especially to a patient's liver, kidneys and lungs, as well as their heart rate and blood pressure.[1] More than three decades ago, B.Braun recognized the environmental and patient risks posed by products containing DEHP and PVC. As a result, B.Braun was the first medical device manufacturer to remove these harmful substances from many products and today is the only supplier that offers a full line of IV containers that are not manufactured with DEHP or PVC. B.Braun is keenly focused on continuing to find alternative methods to manufacture safer products such as the TITAN XL bags. 

B.Braun's Rick Williamson, Vice President of Pharmaceutical Marketing has been a key contributor to the recent success of the expanding US drug delivery portfolio. "We listened to the requests of our customers for fluid containers that are focused on patient safety and that are environmentally friendly," said Williamson. "We are especially proud to offer the only large-volume containers not manufactured with natural rubber latex, DEHP or PVC."

Customers interested in more information can call: 888.422.7286 (888.4BBRAUN) or visit www.BBraunUSA.com.

About TITAN®

The TITAN® XL IV containers offer irrigation and parenteral nutrition solutions for compounding in large volume, flexible bags. TITAN is highly transparent for quick volume monitoring and the innovative, convenient port system allows for easier access. The TITAN XL IV container is not manufactured with natural rubber latex, DEHP or PVC and is compatible with most drugs. TITAN is stored at room temperature. B.Braun will be launching a series of TITAN XL containers for Irrigation and Clinical Nutrition beginning in September, 2013 and throughout 2014. B.Braun's TITAN offerings currently include 3L 0.9% Sodium Chloride for Irrigation.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.

[1] http://www.wsna.org/Topics/Workplace-Environment-You/Environmental-Hazards/PVC-DEHP/


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Joins National Health Organization Supporting Environmental Practices
2. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
3. B. Braun Launches New Patient Website
4. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
5. B. Braun Reveals Customer Satisfaction Survey
6. B. Braun Committed To Improving Patient Safety
7. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
8. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
9. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
10. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
11. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016 Wegener Polyangiitis - Pipeline ... Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 2015, ... pipeline. This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ...
(Date:2/4/2016)... 2016 Frontier Pharma: Chronic Obstructive Pulmonary ... Chronic Obstructive Pulmonary Disease (COPD) ... of the airways and lungs. Persistent breathing difficulties ... disease one of the leading causes of morbidity ... world. COPD is linked to cumulative exposure to ...
(Date:2/4/2016)... -- In response to the opioid abuse epidemic, today Dr. ... Products and Tobacco, along with other FDA leaders, called for ... opioid medications. The plan will focus on policies aimed at ... to effective relief. --> ... risk-benefit paradigm for opioids and ensure that the agency considers ...
Breaking Medicine Technology:
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... the ability to correct pelvic organ prolapse with the latest techniques and the ... at greatest risk for pelvic organ prolapse, particularly after menopause. Other risk factors ...
(Date:2/7/2016)... ... 2016 , ... HealthSmart Holdings, Inc. announced today the launch ... and information to lower the costs, and increase the impact of their healthcare ... healthcare benefits by as much as 22%:, + Price and quality transparency, ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
(Date:2/6/2016)... , ... February 06, 2016 , ... With the ... add warm color grades to their footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. By manipulating each pixel, LUT's can ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):